Targeting the G2/M Transition for Antitumor Therapy
Journal:
Letters in Drug Design & Discovery
Volume:
2
Page:
274-281
Author(s):
J. Yuan and K. Strebhardt
Signal Transducer and Activator of Transcription 5 (STAT5), a Crucial Regulator of Immune and Cancer Cells
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
5
Page:
449-463
Author(s):
Ilka Wittig and Bernd Groner
Telomere Dynamics in Response to Chemotherapy
Journal:
Current Molecular Medicine
Volume:
5
Page:
187-196
Author(s):
N. Beeharry and D. Broccoli
Metal Complexes with Aromatic N-Containing Ligands as Potential Agents in Cancer Treatment
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
137-147
Author(s):
Guanghua Zhao and Huakuan Lin
Gene-Nutrient Interactions in One-Carbon Metabolism
Journal:
Current Drug Metabolism
Volume:
6
Page:
37-46
Author(s):
Simonetta Friso and Sang-Woon Choi
Inhibition of Dipeptidyl Peptidase-4 (DPP-4) - A Novel Approach to Treat Type 2 Diabetes
Journal:
Current Enzyme Inhibition
Volume:
1
Page:
65-73
Author(s):
Bo Ahren
Hypericin - The Facts About a Controversial Agent
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
233-253
Author(s):
A. Kubin, F. Wierrani, U. Burner, G. Alth and W. Grunberger
RNA Interference: A New Targeted Tumour Therapy?
Journal:
Current Cancer Therapy Reviews
Volume:
1
Page:
11-17
Author(s):
Jane M.E. Withey and Mark R. Crompton
Towards Multifunctional Synthetic Vectors
Journal:
Current Gene Therapy
Volume:
4
Page:
445-455
Author(s):
Barbara Demeneix, Zahra Hassani and Jean-Paul Behr
Pharmacogenetics of the Cytochromes P450
Journal:
Current Topics in Medicinal Chemistry
Volume:
4
Page:
1733-1744
Author(s):
Ann K. Daly